Abstract
Proteins and their complexes in structures solved by X-ray crystallography or cryo-EM look rigid. While these structures yield very detailed information, they do not capture critically important property of proteins, their dynamic nature. The very fact that proteins function indicates that they must have moving parts. Structural studies have additional caveats: to obtain structures, proteins are often drastically engineered and placed into highly non-physiological conditions. In contrast to structural studies, biophysical methods, such as EPR and NMR spectroscopy, reveal protein and complex dynamics. Importantly, minimally mutated, virtually wild-type proteins can be used. Here, this issue is discussed using GPCRs and their signal transducers, G proteins and arrestins, as examples. To understand how proteins actually work in living cells, we must keep in mind the limitations of different methods and synthesize the information obtained by all of them.
Similar content being viewed by others
Availability of Data and Materials
No new data are presented and no materials were used.
Change history
04 November 2023
A Correction to this paper has been published: https://doi.org/10.1007/s00723-023-01627-7
Notes
We use systematic names of arrestin proteins, where the number after the dash indicates the order of cloning: arrestin-1 (historic names S-antigen, 48 kDa protein, visual or rod arrestin), arrestin-2 (β-arrestin or β-arrestin1), arrestin-3 (β-arrestin2 or hTHY-ARRX), and arrestin-4 (cone or X-arrestin).
References
D.G. Lambright, J.P. Noel, H.E. Hamm, P.B. Sigler, Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein. Nature 369(6482), 621–628 (1994)
J.A. Hirsch, C. Schubert, V.V. Gurevich, P.B. Sigler, The 2.8 A crystal structure of visual arrestin: a model for arrestin’s regulation. Cell 97(2), 257–269 (1999)
K. Palczewski, T. Kumasaka, T. Hori, C.A. Behnke, H. Motoshima, B.A. Fox, I. Le Trong, D.C. Teller, T. Okada, R.E. Stenkamp, M. Yamamoto, M. Miyano, Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289(5480), 739–745 (2000)
S.G. Rasmussen, H.J. Choi, D.M. Rosenbaum, T.S. Kobilka, F.S. Thian, P.C. Edwards, M. Burghammer, V.R. Ratnala, R. Sanishvili, R.F. Fischetti, G.F. Schertler, W.I. Weis, B.K. Kobilka, Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450(7168), 383–387 (2007)
S.G. Rasmussen, B.T. DeVree, Y. Zou, A.C. Kruse, K.Y. Chung, T.S. Kobilka, F.S. Thian, P.S. Chae, E. Pardon, D. Calinski, J.M. Mathiesen, S.T. Shah, J.A. Lyons, M. Caffrey, S.H. Gellman, J. Steyaert, G. Skiniotis, W.I. Weis, R.K. Sunahara, B.K. Kobilka, Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature 477(7366), 549–555 (2011)
Y. Kang, X.E. Zhou, X. Gao, Y. He, W. Liu, A. Ishchenko, A. Barty, T.A. White, O. Yefanov, G.W. Han, Q. Xu, P.W. de Waal, J. Ke, M.H. Tan, C. Zhang, A. Moeller, G.M. West, B.D. Pascal, N. Van Eps, L.N. Caro, S.A. Vishnivetskiy, R.J. Lee, K.M. Suino-Powell, X. Gu, K. Pal, J. Ma, X. Zhi, S. Boutet, G.J. Williams, M. Messerschmidt, C. Gati, N.A. Zatsepin, D. Wang, D. James, S. Basu, S. Roy-Chowdhury, C.E. Conrad, J. Coe, H. Liu, S. Lisova, C. Kupitz, I. Grotjohann, R. Fromme, Y. Jiang, M. Tan, H. Yang, J. Li, M. Wang, Z. Zheng, D. Li, N. Howe, Y. Zhao, J. Standfuss, K. Diederichs, Y. Dong, C.S. Potter, B. Carragher, M. Caffrey, H. Jiang, H.N. Chapman, J.C. Spence, P. Fromme, U. Weierstall, O.P. Ernst, V. Katritch, V.V. Gurevich, P.R. Griffin, W.L. Hubbell, R.C. Stevens, V. Cherezov, K. Melcher, H.E. Xu, Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser. Nature 523(7562), 561–567 (2015)
T. Zhuang, Q. Chen, M.-K. Cho, S.A. Vishnivetskiy, T.I. Iverson, V.V. Gurevich, W.L. Hubbell, C.R. Sanders, Involvement of distinct arrestin-1 elements in binding to different functional forms of rhodopsin. Proc. Nat. Acad. Sci. USA 110(3), 942–947 (2013)
T. Zhuang, S.A. Vishnivetskiy, V.V. Gurevich, C.R. Sanders, Elucidation of inositol hexaphosphate and heparin interaction sites and conformational changes in arrestin-1 by solution nuclear magnetic resonance. Biochemistry 49(49), 10473–10485 (2010)
M. Elgeti, W.L. Hubbell, DEER Analysis of GPCR conformational Heterogeneity. Biomolecules 11(6), 778 (2021)
D.L. Farrens, C. Altenbach, K. Yang, W.L. Hubbell, H.G. Khorana, Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274(5288), 768–770 (1996)
S.M. Hanson, E.S. Dawson, D.J. Francis, N. Van Eps, C.S. Klug, W.L. Hubbell, J. Meiler, V.V. Gurevich, A model for the solution structure of the rod arrestin tetramer. Structure 16, 924–934 (2008)
S.M. Hanson, D.J. Francis, S.A. Vishnivetskiy, E.A. Kolobova, W.L. Hubbell, C.S. Klug, V.V. Gurevich, Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin. Proc. Natl. Acad. Sci. USA 103, 4900–4905 (2006)
S.M. Hanson, N. Van Eps, D.J. Francis, C. Altenbach, S.A. Vishnivetskiy, V.Y. Arshavsky, C.S. Klug, W.L. Hubbell, V.V. Gurevich, Structure and function of the visual arrestin oligomer. EMBO J. 26, 1726–1736 (2007)
M. Kim, S.M. Hanson, S.A. Vishnivetskiy, X. Song, W.M. Cleghorn, W.L. Hubbell, V.V. Gurevich, Robust self-association is a common feature of mammalian visual arrestin-1. Biochemistry 50, 2235–2242 (2011)
M. Kim, S.A. Vishnivetskiy, N. Van Eps, N.S. Alexander, W.M. Cleghorn, X. Zhan, S.M. Hanson, T. Morizumi, O.P. Ernst, J. Meiler, V.V. Gurevich, W.L. Hubbell, Conformation of receptor-bound visual arrestin. Proc. Nat. Acad. Sci. USA 109(45), 18407–18412 (2012)
A. Manglik, T.H. Kim, M. Masureel, C. Altenbach, Z. Yang, D. Hilger, M.T. Lerch, T.S. Kobilka, F.S. Thian, W.L. Hubbell, R.S. Prosser, B.K. Kobilka, Structural insights into the dynamic process of β2-adrenergic receptor signaling. Cell 161(5), 1101–1111 (2015)
W.M. Oldham, N. Van Eps, A.M. Preininger, W.L. Hubbell, H.E. Hamm, Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins. Nat. Struct. Mol. Biol. 13(9), 772–777 (2006)
N. Van Eps, L.N. Caro, T. Morizumi, A.K. Kusnetzow, M. Szczepek, K.P. Hofmann, T.H. Bayburt, S.G. Sligar, O.P. Ernst, W.L. Hubbell, Conformational equilibria of light-activated rhodopsin in nanodiscs. Proc. Natl. Acad. Sci. USA 114(16), E3268–E3275 (2017)
N. Van Eps, W.M. Oldham, H.E. Hamm, W.L. Hubbell, Structural and dynamical changes in an alpha-subunit of a heterotrimeric G protein along the activation pathway. Proc. Natl. Acad. Sci. USA 103(44), 16194–16199 (2006)
N. Van Eps, A.M. Preininger, N. Alexander, A.I. Kaya, S. Meier, J. Meiler, H.E. Hamm, W.L. Hubbell, Interaction of a G protein with an activated receptor opens the interdomain interface in the alpha subunit. Proc. Natl. Acad. Sci. USA 108(23), 9420–9424 (2011)
Y. Zhuo, S.A. Vishnivetskiy, X. Zhan, V.V. Gurevich, C.S. Klug, Identification of receptor binding-induced conformational changes in non-visual arrestins. J. Biol. Chem. 289(30), 20991–21002 (2014)
V.V. Gurevich, E.V. Gurevich, The molecular acrobatics of arrestin activation. Trends Pharmacol. Sci 25, 59–112 (2004)
P. Samama, S. Cotecchia, T. Costa, R.J. Lefkowitz, A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem. 268(7), 4625–4636 (1993)
V. Cherezov, D.M. Rosenbaum, M.A. Hanson, S.G. Rasmussen, F.S. Thian, T.S. Kobilka, H.J. Choi, P. Kuhn, W.I. Weis, B.K. Kobilka, R.C. Stevens, High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318(5854), 1258–1265 (2007)
S.G. Rasmussen, H.J. Choi, J.J. Fung, E. Pardon, P. Casarosa, P.S. Chae, B.T. Devree, D.M. Rosenbaum, F.S. Thian, T.S. Kobilka, A. Schnapp, I. Konetzki, R.K. Sunahara, S.H. Gellman, A. Pautsch, J. Steyaert, W.I. Weis, B.K. Kobilka, Structure of a nanobody-stabilized active state of the β(2) adrenoceptor. Nature 469(7329), 175–180 (2011)
D.M. Rosenbaum, C. Zhang, J.A. Lyons, R. Holl, D. Aragao, D.H. Arlow, S.G. Rasmussen, H.J. Choi, B.T. Devree, R.K. Sunahara, P.S. Chae, S.H. Gellman, R.O. Dror, D.E. Shaw, W.I. Weis, M. Caffrey, P. Gmeiner, B.K. Kobilka, Structure and function of an irreversible agonist-β(2) adrenoceptor complex. Nature 469(7329), 236–240 (2011)
M.T. Lerch, R.A. Matt, M. Masureel, M. Elgeti, K.K. Kumar, D. Hilger, B. Foys, B.K. Kobilka, W.L. Hubbell, Viewing rare conformations of the β2 adrenergic receptor with pressure-resolved DEER spectroscopy. Proc. Natl. Acad. Sci. USA 117(50), 31824–31831 (2020)
R.A. Dixon, B.K. Kobilka, D.J. Strader, J.L. Benovic, H.G. Dohlman, T. Frielle, M.A. Bolanowski, C.D. Bennett, E. Rands, R.E. Diehl, R.A. Mumford, E.E. Slater, I.S. Sigal, M.G. Caron, R.J. Lefkowitz, C.D. Strader, Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature 321, 75–79 (1986)
G. Milligan, E. Kostenis, Heterotrimeric G-proteins: a short history. Br J. Pharmacol. 147, S46-55 (2006)
J.W. Wisler, K. Xiao, A.R. Thomsen, R.J. Lefkowitz, Recent developments in biased agonism. Curr. Opin. Cell Biol. 27, 18–24 (2014)
C.M. Costa-Neto, L.T. Parreiras-E-Silva, M. Bouvier, A pluridimensional view of biased agonism. Mol. Pharmacol. 90(5), 587–595 (2016)
S.M. DeWire, J.D. Violin, Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology. Circ. Res. 109(2), 205–216 (2011)
H. Indrischek, S.J. Prohaska, V.V. Gurevich, E.V. Gurevich, P.F. Stadler, Uncovering missing pieces: duplication and deletion history of arrestins in deuterostomes. BMC Evol. Biol. 17(1), 163 (2017)
D.S. Eiger, U. Pham, J. Gardner, C. Hicks, S. Rajagopal, GPCR systems pharmacology: a different perspective on the development of biased therapeutics. Am. J. Physiol. Cell Physiol. 322(5), C887-c895 (2022)
V.V. Gurevich, E.V. Gurevich, Biased GPCR signaling: possible mechanisms and inherent limitations. Pharmacol. Ther. 211, 107540 (2020)
L.M. Wingler, C. McMahon, D.P. Staus, R.J. Lefkowitz, A.C. Kruse, Distinctive activation mechanism for angiotensin receptor revealed by a synthetic nanobody. Cell 176(3), 479–490 (2019)
M. Natochin, M. Moussaif, N.O. Artemyev, Probing the mechanism of rhodopsin catalyzed transducin activation. J. Neurochem. 77, 202–210 (2001)
R.O. Dror, T.J. Mildorf, D. Hilger, A. Manglik, D.W. Borhani, D.H. Arlow, A. Philippsen, N. Villanueva, Z. Yang, M.T. Lerch, W.L. Hubbell, B.K. Kobilka, R.K. Sunahara, D.E. Shaw, SIGNAL TRANSDUCTION. Structural basis for nucleotide exchange in heterotrimeric G proteins. Science 348(6241), 1361–1365 (2015)
E.V. Gurevich, J.J. Tesmer, A. Mushegian, V.V. Gurevich, G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol. Ther. 133(1), 40–46 (2012)
A.D. Tóth, S. Prokop, P. Gyombolai, P. Várnai, A. Balla, V.V. Gurevich, L. Hunyady, G. Turu, Heterologous phosphorylation-induced formation of a stability lock permits regulation of inactive receptors by β-arrestins. J. Biol. Chem. 293(3), 876–892 (2018)
C.V. Carman, J.L. Benovic, G-protein-coupled receptors: turn-ons and turn-offs. Curr. Opin. Neurobiol. 8, 335–344 (1998)
V.V. Gurevich, E.V. Gurevich, Plethora of functions packed into 45 kDa arrestins: biological implications and possible therapeutic strategies. Cell. Mol. Life Sci. 76(22), 4413–4421 (2019)
Y.K. Peterson, L.M. Luttrell, The diverse roles of arrestin scaffolds in G protein-coupled receptor signaling. Pharmacol. Rev. 69(3), 256–297 (2017)
M. Han, V.V. Gurevich, S.A. Vishnivetskiy, P.B. Sigler, C. Schubert, Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane translocation. Structure 9(9), 869–880 (2001)
R.B. Sutton, S.A. Vishnivetskiy, J. Robert, S.M. Hanson, D. Raman, B.E. Knox, M. Kono, J. Navarro, V.V. Gurevich, Crystal structure of cone arrestin at 2.3Å: evolution of receptor specificity. J. Mol. Biol. 354, 1069–1080 (2005)
X. Zhan, L.E. Gimenez, V.V. Gurevich, B.W. Spiller, Crystal structure of arrestin-3 reveals the basis of the difference in receptor binding between two non-visual arrestins. J. Mol. Biol. 406, 467–478 (2011)
S.K. Milano, H.C. Pace, Y.M. Kim, C. Brenner, J.L. Benovic, Scaffolding functions of arrestin-2 revealed by crystal structure and mutagenesis. Biochemistry 41(10), 3321–3328 (2002)
J. Granzin, U. Wilden, H.W. Choe, J. Labahn, B. Krafft, G. Buldt, X-ray crystal structure of arrestin from bovine rod outer segments. Nature 391(6670), 918–921 (1998)
C.L. Sander, J. Luu, K. Kim, D. Furkert, K. Jang, J. Reichenwallner, M. Kang, H.J. Lee, B.T. Eger, H.W. Choe, D. Fiedler, O.P. Ernst, Y.J. Kim, K. Palczewski, P.D. Kiser, Structural evidence for visual arrestin priming via complexation of phosphoinositols. Structure 30(2), 263–277 (2022)
S.A. Vishnivetskiy, D.J. Francis, N. Van Eps, M. Kim, S.M. Hanson, C.S. Klug, W.L. Hubbell, V.V. Gurevich, The role of arrestin alpha-helix I in receptor binding. J. Mol. Biol. 395, 42–54 (2010)
S.M. Hanson, W.M. Cleghorn, D.J. Francis, S.A. Vishnivetskiy, D. Raman, X. Song, K.S. Nair, V.Z. Slepak, C.S. Klug, V.V. Gurevich, Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity. J. Mol. Biol. 368(2), 375–387 (2007)
S.M. Hanson, D.J. Francis, S.A. Vishnivetskiy, C.S. Klug, V.V. Gurevich, Visual arrestin binding to microtubules involves a distinct conformational change. J. Biol. Chem. 281, 9765–9772 (2006)
N. Wu, S.M. Hanson, D.J. Francis, S.A. Vishnivetskiy, M. Thibonnier, C.S. Klug, M. Shoham, V.V. Gurevich, Arrestin binding to calmodulin: a direct interaction between two ubiquitous signaling proteins. J. Mol. Biol. 364, 955–963 (2006)
S.A. Vishnivetskiy, L.E. Gimenez, D.J. Francis, S.M. Hanson, W.L. Hubbell, C.S. Klug, V.V. Gurevich, Few residues within an extensive binding interface drive receptor interaction and determine the specificity of arrestin proteins. J. Biol. Chem. 286, 24288–24299 (2011)
X. Song, D. Raman, E.V. Gurevich, S.A. Vishnivetskiy, V.V. Gurevich, Visual and both non-visual arrestins in their : “inactive” conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm. J. Biol. Chem. 281, 21491–21499 (2006)
M. Breitman, S. Kook, L.E. Gimenez, B.N. Lizama, M.C. Palazzo, E.V. Gurevich, V.V. Gurevich, Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant. J. Biol. Chem. 287(23), 19653–19664 (2012)
M.R. Ahmed, X. Zhan, X. Song, S. Kook, V.V. Gurevich, E.V. Gurevich, Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitination. Biochemistry 50, 3749–3763 (2011)
V.V. Gurevich, E.V. Gurevich, Extensive shape shifting underlies functional versatility of arrestins. Curr. Opin. Cell Biol. 27, 1–9 (2014)
C. Schubert, J.A. Hirsch, V.V. Gurevich, D.M. Engelman, P.B. Sigler, K.G. Fleming, Visual arrestin activity may be regulated by self-association. J. Biol. Chem. 274, 21186–21190 (1999)
S.M. Hanson, S.A. Vishnivetskiy, W.L. Hubbell, V.V. Gurevich, Opposing effects of inositol hexakisphosphate on rod arrestin and arrestin2 self-association. Biochemistry 47, 1070–1075 (2008)
S.A. Vishnivetskiy, Q. Chen, M.C. Palazzo, E.K. Brooks, C. Altenbach, T.M. Iverson, W.L. Hubbell, V.V. Gurevich, Engineering visual arrestin-1 with special functional characteristics. J. Biol. Chem. 288(17), 11741–11750 (2013)
Q. Chen, Y. Zhuo, P. Sharma, I. Perez, D.J. Francis, S. Chakravarthy, S.A. Vishnivetskiy, S. Berndt, S.M. Hanson, X. Zhan, E.K. Brooks, C. Altenbach, W.L. Hubbell, C.S. Klug, T.M. Iverson, V.V. Gurevich, An eight amino acid segment controls oligomerization and preferred conformation of the two non-visual arrestins. J. Mol. Biol. 433(4), 166790 (2021)
S.K. Milano, Y.M. Kim, F.P. Stefano, J.L. Benovic, C. Brenner, Nonvisual arrestin oligomerization and cellular localization are regulated by inositol hexakisphosphate binding. J. Biol. Chem. 281, 9812–9823 (2006)
Q. Chen, N.A. Perry, S.A. Vishnivetskiy, S. Berndt, N.C. Gilbert, Y. Zhuo, P.K. Singh, J. Tholen, M.D. Ohi, E.V. Gurevich, C.A. Brautigam, K.S. Klug, V.V. Gurevich, T.M. Iverson, Structural basis of arrestin-3 activation and signaling. Nat. Commun. 8(1), 1427 (2017)
S. Samaranayake, S.A. Vishnivetskiy, C.R. Shores, K.C. Thibeault, S. Kook, J. Chen, M.E. Burns, E.V. Gurevich, V.V. Gurevich, Biological role of arrestin-1 oligomerization. J. Neurosci. 40(42), 8055–8069 (2020)
Y. Imamoto, K. Kojima, R. Maeda, Y. Shichida, T. Oka, Role of monomer/tetramer equilibrium of rod visual arrestin in the interaction with phosphorylated rhodopsin. Int. J. Mol. Sci. 24(5), 4963 (2023)
T.H. Bayburt, S.A. Vishnivetskiy, M. McLean, T. Morizumi, C.-C. Huang, J.J. Tesmer, O.P. Ernst, S.G. Sligar, V.V. Gurevich, Rhodopsin monomer is sufficient for normal rhodopsin kinase (GRK1) phosphorylation and arrestin-1 binding. J. Biol. Chem. 286, 1420–1428 (2011)
S.M. Hanson, E.V. Gurevich, S.A. Vishnivetskiy, M.R. Ahmed, X. Song, V.V. Gurevich, Each rhodopsin molecule binds its own arrestin. Proc. Nat. Acad. Sci. USA 104, 3125–3128 (2007)
X.E. Zhou, Y. He, P.W. de Waal, X. Gao, Y. Kang, N. Van Eps, Y. Yin, K. Pal, D. Goswami, T.A. White, A. Barty, N.R. Latorraca, H.N. Chapman, W.L. Hubbell, R.O. Dror, R.C. Stevens, V. Cherezov, V.V. Gurevich, P.R. Griffin, O.P. Ernst, K. Melcher, H.E. Xu, Identification of phosphorylation codes for arrestin recruitment by G protein-coupled receptors. Cell 170(3), 457–469 (2017)
J. Bous, A. Fouillen, H. Orcel, S. Trapani, X. Cong, S. Fontanel, J. Saint-Paul, J. Lai-Kee-Him, S. Urbach, N. Sibille, R. Sounier, S. Granier, B. Mouillac, P. Bron, Structure of the vasopressin hormone-V2 receptor-β-arrestin1 ternary complex. Sci. Adv. 8(35), eabo7761 (2022)
C. Cao, X. Barros-Álvarez, S. Zhang, K. Kim, M.A. Dämgen, O. Panova, C.M. Suomivuori, J.F. Fay, X. Zhong, B.E. Krumm, R.H. Gumpper, A.B. Seven, M.J. Robertson, N.J. Krogan, R. Hüttenhain, D.E. Nichols, R.O. Dror, G. Skiniotis, B.L. Roth, Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD. Neuron 110(19), 3154–3167 (2022)
W. Huang, M. Masureel, Q. Qianhui, J. Janetzko, A. Inoue, H.E. Kato, M.J. Robertson, K.C. Nguyen, J.S. Glenn, G. Skiniotis, B.K. Kobilka, Structure of the neurotensin receptor 1 in complex with β-arrestin 1. Nature 579(7798), 303–308 (2020)
Y. Lee, T. Warne, R. Nehmé, S. Pandey, H. Dwivedi-Agnihotri, M. Chaturvedi, P.C. Edwards, J. García-Nafría, A.G.W. Leslie, A.K. Shukla, C.G. Tate, Molecular basis of β-arrestin coupling to formoterol-bound β(1)-adrenoceptor. Nature 583(7818), 862–866 (2020)
D.P. Staus, H. Hu, M.J. Robertson, A.L.W. Kleinhenz, L.M. Wingler, W.D. Capel, N.R. Latorraca, R.J. Lefkowitz, G. Skiniotis, Structure of the M2 muscarinic receptor-β-arrestin complex in a lipid nanodisc. Nature 579(7798), 297–302 (2020)
W. Yin, Z. Li, M. Jin, Y.L. Yin, P.W. de Waal, K. Pal, Y. Yin, X. Gao, Y. He, J. Gao, X. Wang, Y. Zhang, H. Zhou, K. Melcher, Y. Jiang, Y. Cong, X. Edward Zhou, X. Yu, Xu. Eric, A complex structure of arrestin-2 bound to a G protein-coupled receptor. Cell Res. 29(12), 971–983 (2019)
A. Schleicher, H. Kuhn, K.P. Hofmann, Kinetics, binding constant, and activation energy of the 48-kDa protein-rhodopsin complex by extra-metarhodopsin II. Biochemistry 28(4), 1770–1775 (1989)
K. Palczewski, J. Buczyłko, N.R. Imami, J.H. McDowell, P.A. Hargrave, Role of the carboxyl-terminal region of arrestin in binding to phosphorylated rhodopsin. J. Biol. Chem. 266, 15334–15339 (1991)
V.V. Gurevich, S.M. Hanson, X. Song, S.A. Vishnivetskiy, E.V. Gurevich, The functional cycle of visual arrestins in photoreceptor cells. Prog. Retin. Eye Res. 30(6), 405–430 (2011)
V.V. Gurevich, J.L. Benovic, Visual arrestin binding to rhodopsin: diverse functional roles of positively charged residues within the phosphorylation-recognition region of arrestin. J. Biol. Chem. 270(11), 6010–6016 (1995)
V.V. Gurevich, The selectivity of visual arrestin for light-activated phosphorhodopsin is controlled by multiple nonredundant mechanisms. J. Biol. Chem. 273, 15501–15506 (1998)
W.B. Asher, D.S. Terry, G.G.A. Gregorio, A.W. Kahsai, A. Borgia, B. Xie, A. Modak, Y. Zhu, W. Jang, A. Govindaraju, L.Y. Huang, A. Inoue, N.A. Lambert, V.V. Gurevich, L. Shi, R.J. Lefkowitz, S.C. Blanchard, J.A. Javitch, GPCR-mediated β-arrestin activation deconvoluted with single-molecule precision. Cell 185(10), 1661–1675 (2022)
A.K. Shukla, A. Manglik, A.C. Kruse, K. Xiao, R.I. Reis, W.C. Tseng, D.P. Staus, D. Hilger, S. Uysal, L.Y. Huang, M. Paduch, P. Tripathi-Shukla, A. Koide, S. Koide, W.I. Weis, A.A. Kossiakoff, B.K. Kobilka, R.J. Lefkowitz, Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide. Nature 497(7447), 137–141 (2013)
Y. Aydin, T. Böttke, J.H. Lam, S. Ernicke, A. Fortmann, M. Tretbar, B. Zarzycka, V.V. Gurevich, V. Katritch, I. Coin, Structural details of a class B GPCR-arrestin complex revealed by genetically encoded crosslinkers in living cells. Nat. Commun. 14(1), 1151 (2023)
J.A. Ballesteros, H. Weinstein, Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25, 366–428 (1995)
J. Kim, S. Ahn, X.R. Ren, E.J. Whalen, E. Reiter, H. Wei, R.J. Lefkowitz, Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling. Proc. Nat. Acad. Sci. USA 102, 1442–1447 (2005)
K.N. Nobles, K. Xiao, S. Ahn, A.K. Shukla, C.M. Lam, S. Rajagopal, R.T. Strachan, T.Y. Huang, E.A. Bressler, M.R. Hara, S.K. Shenoy, S.P. Gygi, R.J. Lefkowitz, Distinct phosphorylation sites on the {beta}2-adrenergic receptor establish a barcode that encodes differential functions of {beta}-arrestin. Sci. Signal 4, 51 (2011)
M. Choi, D.P. Staus, L.M. Wingler, S. Ahn, B. Pani, W.D. Capel, R.J. Lefkowitz, G protein-coupled receptor kinases (GRKs) orchestrate biased agonism at the β2-adrenergic receptor. Sci. Signal 11, 544 (2018)
A.I. Kaya, N.A. Perry, V.V. Gurevich, T.M. Iverson, Phosphorylation barcode-dependent signal bias of the dopamine D1 receptor. Proc. Nat. Acad. Sci. USA 117(25), 14139–14149 (2020)
X.R. Ren, E. Reiter, S. Ahn, J. Kim, W. Chen, R.J. Lefkowitz, Different G protein-coupled receptor kinases govern G protein and beta-arrestin mediated signaling of V2 vasopressin receptor. Proc. Nat. Acad. Sci. USA 102, 1448–1453 (2005)
Acknowledgements
This work was supported by NIH Grants EY011500, GM122491, and Cornelius Vanderbilt Endowed Chair (Vanderbilt University).
Funding
Supported in part by NIH RO1 EY011500, R35 GM122491, and Cornelius Vanderbilt Endowed Chair (Vanderbilt University).
Author information
Authors and Affiliations
Contributions
VVG wrote and edited the manuscript. EVG edited the manuscript and created figures.
Corresponding author
Ethics declarations
Conflict of Interests
The authors declare no competing interests.
Ethical approval
No human or animal studies.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised as the second author’s name Eugenia V. Gurevich was incorrectly written as Eugenis V. Gurevich.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gurevich, V.V., Gurevich, E.V. Dynamic Nature of Proteins is Critically Important for Their Function: GPCRs and Signal Transducers. Appl Magn Reson 55, 11–25 (2024). https://doi.org/10.1007/s00723-023-01561-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00723-023-01561-8